Stock Events

Stock Events

Rapid Therapeutic Science Laboratories 

$0.000100
5
-$0.00-0% Monday 13:30

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0074
52W Low
0.0001
Volume
-
Avg. Volume
-
Mkt Cap
1,898.7
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.2
-0.13
-0.07
-0
Expected EPS
N/A
Actual EPS
-0.03

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-366,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RTSL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap151.74M
Corbus Pharmaceuticals is involved in the development of novel therapeutics to treat inflammatory and fibrotic diseases using cannabinoid receptor agonists, making it a direct competitor.
Charlottes Web
CWBHF
Mkt Cap107.68M
Charlotte's Web Holdings operates in the hemp-derived CBD wellness products, competing with RTSL in the broader cannabinoid product market.
Tilray Brands
TLRY
Mkt Cap601.68M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a competitor in the cannabinoid-based product market.
Canopy Growth
CGC
Mkt Cap449.08M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, competing across several of RTSL's target markets.
Aurora Cannabis
ACB
Mkt Cap188.3M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with RTSL in the cannabis market.
Green Thumb Industries
GTBIF
Mkt Cap1.74B
Green Thumb Industries Inc. manufactures and sells a variety of cannabis products in the United States, competing in the cannabis market with RTSL.

About

Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.
Show more...
CEO
Mr. Donal R. Schmidt Jr.
Employees
3
Country
United States
ISIN
US7534312043

Listings

OTC Link
US
RTSL

0 Comments

Share your thoughts

FAQ

What is Rapid Therapeutic Science Laboratories stock price today?▼
The current price of RTSL is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch Rapid Therapeutic Science Laboratories stock price performance more closely on the chart.
What is Rapid Therapeutic Science Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rapid Therapeutic Science Laboratories stocks are traded under the ticker RTSL.
Is Rapid Therapeutic Science Laboratories stock price growing?▼
RTSL stock has fallen by -0% compared to the previous week, the month change is a -98.33% fall, over the last year Rapid Therapeutic Science Laboratories has showed a -98.65% decrease.
What is Rapid Therapeutic Science Laboratories market cap?▼
Today Rapid Therapeutic Science Laboratories has the market capitalization of 1,898.7
What were Rapid Therapeutic Science Laboratories earnings last quarter?▼
RTSL earnings for the last quarter are -0.03 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rapid Therapeutic Science Laboratories revenue for the last year?▼
Rapid Therapeutic Science Laboratories revenue for the last year amounts to 0 USD.
What is Rapid Therapeutic Science Laboratories net income for the last year?▼
RTSL net income for the last year is -366,000 USD.
How many employees does Rapid Therapeutic Science Laboratories have?▼
As of June 16, 2026, the company has 3 employees.
In which sector is Rapid Therapeutic Science Laboratories located?▼
Rapid Therapeutic Science Laboratories operates in the Health & Wellness sector.
When did Rapid Therapeutic Science Laboratories complete a stock split?▼
The last stock split for Rapid Therapeutic Science Laboratories was on March 31, 2022 with a ratio of 1:25.
Where is Rapid Therapeutic Science Laboratories headquartered?▼
Rapid Therapeutic Science Laboratories is headquartered in De Leon, United States.